Issue link: https://www.e-digitaleditions.com/i/1481708
What sets us apart from other modifi ed cyclodextrins? A team of experts dedicated to moving your product forward. • Decades of experience in the pharmaceutical industry developing parenteral, oral, ophthalmic, nasal and inhalation formulations with Captisol and other cyclodextrins • Recent addition of internal resources and analytical tools will provide greater responsiveness for collaborative feasibility and development programs • The team can help create your product or assist in your development, safety studies, regulatory or manufacturing • Our team has successfully completed or assisted with orphan designations and approvals, preclinical, CMC and clinical development for ANDA, 505b2 and traditional NDA programs • Academic or Industry, the Captisol team is available to discuss your application, evaluate and potentially participate in your research project or developing the concept Ready? Call 858-550-5632 or email cdinfo@captisol.com Captisol.com